Characteristics of the 40 Subjects with Type 1 Diabetes.

Unless otherwise indicated all data are presented as mean ± SD.Comparisons are made between end-of-treatment and baseline, or post-treatment and baseline within the Total Cohort and within each of the Insulin Pump and MDI subgroups.* For the analysis of AGP parameters, evaluable data from baseline and end of treatment periods was available for 39 subjects. The post-treatment period included 38 evaluable subjects due to missing data from a subject in the MDI group.† Indicates p180mg/dL post-treatment comparison with baseline for the MDI Group, p = 0.04. Percentage of Time Spent 70-140mg/dL post-treatment comparison with baseline for the MDI Group, p = 0.003.Characteristics of the 40 Subjects with Type 1 Diabetes.